Viewing Study NCT02448303


Ignite Creation Date: 2025-12-24 @ 7:32 PM
Ignite Modification Date: 2026-02-26 @ 4:18 PM
Study NCT ID: NCT02448303
Status: COMPLETED
Last Update Posted: 2019-09-12
First Post: 2015-05-14
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Pembrolizumab Alone and In Combination With Acalabrutinib (ACP-196) in Subjects With Advanced Non-small Cell Lung Cancer
Sponsor:
Organization: